Vanda Pharmaceuticals
VNDA
#8812
Rank
HK$1.63 B
Marketcap
HK$27.02
Share price
-6.13%
Change (1 day)
-32.47%
Change (1 year)

EPS for Vanda Pharmaceuticals (VNDA)

EPS in 2026 (TTM): -HK$36.08

According to Vanda Pharmaceuticals's latest financial reports the company's current EPS (TTM) is -HK$36.23. In 2025 the company made an earnings per share (EPS) of -HK$29.25 a decrease over its 2024 EPS that were of -HK$2.51.

EPS history for Vanda Pharmaceuticals from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-HK$36.0823.35%
2025-HK$29.251065.63%
2024-HK$2.51-710.9%
2023HK$0.41-56.35%
2022HK$0.94-80%
2021HK$4.71
2019HK$17.02334%
2018HK$3.92-247.06%
2017-HK$2.67-19.05%
2016-HK$3.29-55.32%
2015-HK$7.37-347.37%
2014HK$2.98-156.72%
2013-HK$5.25-31.63%
2012-HK$7.69

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
HK$52.39-244.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
HK$41.17-213.64%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
HK$5.57-115.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
HK$242.26-768.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
HK$7.79-121.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
HK$35.45-197.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Titan Pharmaceuticals
TTNP
-HK$34.43-4.98%๐Ÿ‡บ๐Ÿ‡ธ USA